Literature DB >> 25712235

Renal diseases in adults with cystic fibrosis: a 40 year single centre experience.

M J Wilcock1,2, A Ruddick3, K M Gyi3, M E Hodson3.   

Abstract

BACKGROUND: There is a sizable literature describing renal disease in patients with cystic fibrosis. Previous studies have focused on single disease processes alone, most commonly renal stone disease or acute kidney injury. In this study we report for the first time on the prevalence of all forms of renal disease in a cystic fibrosis population.
METHODS: A retrospective review of adult patients with cystic fibrosis attending the Adult Cystic Fibrosis Department at the Royal Brompton Hospital was carried out by searching the department's database to identify patients with renal problems and subsequently retrieving clinical information from medical notes.
RESULTS: The prevalence of all renal diseases in our population was 5.1 %. The most commonly identified problem was renal stones. At 2.0 % the prevalence of renal stones in adult patients with cystic fibrosis was comparable to the general population. A range of other renal diseases were identified, the next most common being drug-induced acute kidney injury.
CONCLUSIONS: A range of cystic fibrosis independent and attributable diseases has been identified but no cystic fibrosis specific disease. In contrast to other cystic fibrosis centres no increased prevalence of renal stones was found.

Entities:  

Keywords:  Acute kidney injury; Chronic kidney disease; Cystic fibrosis; Renal stones

Mesh:

Year:  2015        PMID: 25712235     DOI: 10.1007/s40620-015-0179-z

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  30 in total

Review 1.  The cystic fibrosis transmembrane regulator (CFTR) in the kidney.

Authors:  M M Morales; D Falkenstein; A G Lopes
Journal:  An Acad Bras Cienc       Date:  2000-09       Impact factor: 1.753

2.  Section on Urology: report of the annual meeting, San Francisco, California, 1995.

Authors:  D B Joseph
Journal:  Pediatrics       Date:  1996-07       Impact factor: 7.124

3.  IgA nephropathy in cystic fibrosis.

Authors:  G Stirati; M Antonelli; C Fofi; S Fierimonte; G Pecci
Journal:  J Nephrol       Date:  1999 Jan-Feb       Impact factor: 3.902

4.  Urolithiasis and cystic fibrosis.

Authors:  L A Matthews; C F Doershuk; R C Stern; M I Resnick
Journal:  J Urol       Date:  1996-05       Impact factor: 7.450

5.  Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.

Authors:  M Al-Aloul; H Miller; S Alapati; P A Stockton; M J Ledson; M J Walshaw
Journal:  Pediatr Pulmonol       Date:  2005-01

6.  Is there a risk for kidney stone formation in cystic fibrosis?

Authors:  H Böhles; D Michalk
Journal:  Helv Paediatr Acta       Date:  1982-06

7.  Renal involvement in cystic fibrosis: diseases spectrum and clinical relevance.

Authors:  Yasmina Yahiaoui; Mathieu Jablonski; Dominique Hubert; Helen Mosnier-Pudar; Laure-Hélène Noël; Marc Stern; Dominique Grenet; Jean-Pierre Grünfeld; Dominique Chauveau; Fadi Fakhouri
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

Review 8.  Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy.

Authors:  Li Li; Shawn Somerset
Journal:  Dig Liver Dis       Date:  2014-07-19       Impact factor: 4.088

9.  Which factors account for renal stone formation in cystic fibrosis?

Authors:  R von der Heiden; A P G Balestra; M G Bianchetti; C Casaulta Aebischer; P E Mullis; K Lippuner; P Jaeger
Journal:  Clin Nephrol       Date:  2003-03       Impact factor: 0.975

10.  Cystic fibrosis and calcium oxalate nephrolithiasis.

Authors:  A S Chidekel; T F Dolan
Journal:  Yale J Biol Med       Date:  1996 Jul-Aug
View more
  4 in total

1.  Renal Function in Patients with Cystic Fibrosis: A Single-Center Study.

Authors:  Marta Rachel; Sabina Galiniak; Marek Biesiadecki; Agnieszka Gala-Błądzińska
Journal:  Int J Environ Res Public Health       Date:  2022-04-29       Impact factor: 4.614

2.  Urinary stone disease prevalence and associations in cystic fibrosis.

Authors:  Jonathan B Zuckerman; Eric N Taylor; Jeremy F Wright; Wendy Y Craig; F L Lucas; David S Goldfarb
Journal:  Urolithiasis       Date:  2021-02-06       Impact factor: 3.436

Review 3.  Cystic Fibrosis-Related Diabetes.

Authors:  Kayani Kayani; Raihan Mohammed; Hasan Mohiaddin
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-20       Impact factor: 5.555

4.  An Integrated Proteomics and Metabolomics Strategy for the Mechanism of Calcium Oxalate Crystal-Induced Kidney Injury.

Authors:  Songyan Gao; Yufan Chao; Na Li; Henghui Li; Hongxia Zhao; Xinru Liu; Wei Chen; Xin Dong
Journal:  Front Med (Lausanne)       Date:  2022-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.